Scope of the Report The report titled “The US Hip Reconstruction Market: Size, Trends and Forecasts (2021-2025 Edition)”, provides an in depth analysis of the US hip reconstruction market by value, by procedure volume, by type, etc. The report also provides a detailed analysis of the US primary total hip reconstruction market by value, and by type.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the US hip reconstruction market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The hip reconstruction market is dominated by few players, but there are other new players, private label players as well. However, the competition in the US hip reconstruction market is dominated by Zimmer Biomet Holdings, Inc., Johnson & Johnson, Stryker Corporation and Smith & Nephew Plc, who are also profiled with their financial information and respective business strategies.
Company Coverage Zimmer Biomet Holdings Inc. Johnson & Johnson Stryker Corporation Smith & Nephew Plc
Executive Summary The hip reconstruction market can be segmented on the basis of type. There are four major types of hip reconstruction procedures: Primary Total Hip Reconstruction, Partial Hip Reconstruction, Hip Resurfacing and Revision Hip Reconstruction. Primary Total Hip Reconstruction is further segmented into three types: Cemented Hip Reconstruction, Cementless Hip Reconstruction and Hybrid Hip Reconstruction.
The US hip reconstruction market has increased at a significant CAGR over the years and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The hip reconstruction market is expected to increase due to aging population, growing prevalence of arthritis, increasing obesity, growth in chronic diseases, escalating healthcare expenditure, etc. Yet the market faces some challenges such as high cost involved, regulatory risk, etc.
Our reports have been used by over 10K customers, including:
The global shoulder arthroplasty market is expected to reach US$2.40 billion in 2023, recording a CAGR of 7.31% in the duration spanning 2019-2023. The factors such as an upsurge in ageing population, growing healthcare expenditure, longer life expectancy, rising prevalence of arthritis and increasing global diabetic population are expected...
General Medicine And Specialty Medicine
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.